Zoan BioMed was the first company to be introduced at the conference – ‘Bringing Blue Innovation to the Market’. We presented our business and detailed our commercialisation plans after FDA approval. Of particular interest was the sustainability credentials of the Zoan BioMed platform – the first company in its industry to commit towards a short term goal of being carbon neutral in its production facility. Thank you to moderator Vincent Favrel and all our friends at the European Climate, Infrastructure and Environment Executive Agency.
Novel Collaboration between Zoan Biomed and University of Galway to Assess Laboratory Bone Formation
Zoan Biomed and the University of Galway to develop high throughput rapid assessment methods for biocompatibility and osteogenic potential of orthopaedic scaffold; reducing time to clinical data and developing a path to remove the need for animal testing.
Zoan Biomed were delighted to be featured in the August edition of the leading orthopaedic industry magazine, Bonezone, a popular US publication covering the most prominent breakthroughs in Orthopaedics.
We were delighted to have the opportunity to host, Mary Rodgers (CEO, PorterShed Galway) ,
Kevin Beiner (Senior Vice President and Regional Executive Director, Northwell Health) Elaine
Brennan (Executive Director & Chief Commercialization Officer at Northwell Health) Jennifer
Scanlon (AVP Strategic Partnerships at Northwell Health) to our facility last week.
Dublin, June 2022 Zoan Biomed was chosen as one of the finalists in the KPMG Global Tech Innovator series. With 70+ impressive entrants representing the very best innovations in Ireland, the 8 finalists got to present to some of Ireland’s leading business personalities.
The Zoan Biomed innovation was lauded for its uniqueness, impact to industry and sustainability credentials.
To find out more about Zoan BioMed get in touch